A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis

British Journal of Surgery

Volumn 93, Issue 10, 2006, Pages 1258-1264

  Latchford, A R ^a   Sturt, N J H ^a   Neale, K ^a   Rogers, P A ^a   Phillips, R K S ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ABDOMINAL SURGERY; ADENOMATOUS POLYP; ADULT; CANCER MORTALITY; CANCER SURGERY; CLINICAL ARTICLE; COLON RESECTION; CONTROLLED STUDY; DATA BASE; DESMOID TUMOR; DISEASE ASSOCIATION; DUODENUM CANCER; FEMALE; FEVER; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; PARENTERAL NUTRITION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REVIEW; SALVAGE THERAPY; SMALL INTESTINE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR RECURRENCE; VOMITING; WOUND INFECTION;

ABDOMINAL NEOPLASMS; ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; FEMALE; FIBROMATOSIS, AGGRESSIVE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33749587321     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5425     Document Type: Review

References (23)

1. Nugent KP, Spigelman AD, Phillips RKS. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1993; 36: 1059-1062.
2. Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990; 33: 639-642.
3. Bertario L, Presciuttini S, Sala P, Rossetti C, Pietroiusti M. Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry. Italian Registry of Familial Polyposis Writing Committee. Semin Surg Oncol 1994; 10: 225-234.
4. Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJA, Booker SV et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994; 35: 377-381.
5. Lofti AM, Dozois RR, Gordon H, Hruska LS, Weiland LH, Carryer PW et al. Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment. Int J Colorectal Dis 1989; 4: 30-36.
6. Bertario L, Russo A, Sala P, Eboli M, Giarola M, D'amico D et al. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 2001; 95: 102-107.
7. Friedl W, Caspari R, Sengteller M, Uhlhaas S, Lamberti C, Jungck M et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 2001; 48: 515-521.
8. Heinimann K, Mullhaupt B, Weber W, Attenhofer M, Scott RJ, Fried M et al. Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status. Gut 1998; 43: 675-679.
9. Clark SK, Phillips RKS. Desmoids in familial adenomatous polyposis. Br J Surg 1996; 83: 1494-1504.
10. Caspari R, Olschwang S, Friedl W, Mandl M, Boisson C, Boker T et al. Familial adenomatous polyposis: desmoid tumours and lack of opthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995; 4: 337-340.
11. Davies DR, Armstrong JG, Thakker N, Horner K, Guy SP, Clancy T et al. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 1995; 57: 1151-1158.
12. Sturt NJH, Gallagher MC, Bassett P, Philp CR, Neale KF, Tomlinson IP et al. Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 2004; 53: 1832-1836.
13. Church JM. Desmoid tumors in patients with familial adenomatous polyposis. Semin Colon Rectal Surg. 1995; 6: 29-32.
14. Tsukada K, Church JM, Jagelman DG, Fazio VW, McGannon E, George CR et al. Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. Dir Colon Rectum 1992; 35: 29-33.
15. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 2004; 100: 612-620.
16. Phillips SR, A'Hern R, Thomas JM. Aggressive fibromatosis of the abdominal wall, limbs and limb girdles. Br J Surg 2004; 91: 1624-1629.
17. Clark SK, Neale KF, Landgrebe JC, Phillips RKS. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 1999; 86: 1185-1189.
18. Middleton SB, Phillips RK. Surgery for large intra-abdominal desmoid tumors: report of four cases. Dis Colon Rectum 2000; 43: 1759-1762; discussion 1762-1763.
19. Lofti AM, Dozois RR, Gordon H, Hruska LS, Weiland LH, Carryer PW et al. Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment. Int J Colorectal Dis 1989; 4: 30-36.
20. Schulz-Ertner D, Zierhut D, Mende U, Harms W, Branitzki P, Wannenmacher M. The role of radiation therapy in the management of desmoid tumors. Strahlenther Onkol 2002; 178: 78-83.
21. O'Dea FJ, Wunder J, Bell RS, Griffin AM, Catton C, O'Sullivan B. Preoperative radiotherapy is effective in the treatment of fibromatosis. Clin Orthop Relat Res 2003; 415: 19-24.
22. Duggal A, Dickinson IC, Sommerville S, Gallie P. The management of extra-abdominal desmoid tumours. Int Orthop 2004; 28: 252-256.
23. Micke O, Seegenschmiedt MH. Radiation therapy for aggressive fibromatosis (desmoid tumors): results of a national Patterns of Care Study. Int J Radiat Oncol Biol Phys 2005; 61: 882-891.